The use of a small molecule inhibitor (STM2457) that targets the m6A writer protein, METTL3, was shown to diminish infectious viral particle release and sense-strand-derived viral transcripts in vitro, indicative that it may be therapeutically efficacious early in viral infection [95]. The gene discussed is METTL3; the disease is viral infectious disease.